25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Korean Drug Co. Ltd
Buy, Hold or Sell?

Let's analyze Korean Drug Co. Ltd together

I guess you are interested in Korean Drug Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Korean Drug Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Korean Drug Co. Ltd

I send you an email if I find something interesting about Korean Drug Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Korean Drug Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Korean Drug Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.10
When do you have the money?
1 year
How often do you get paid?
86.2%

What is your share worth?

Current worth
₩7,196.40
Expected worth in 1 year
₩6,858.20
How sure are you?
86.2%

+ What do you gain per year?

Total Gains per Share
₩-188.31
Return On Investment
-4.1%

For what price can you sell your share?

Current Price per Share
₩4,560.00
Expected price per share
₩4,440 - ₩5,721
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Korean Drug Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩4,560.00

2.2. Growth of Korean Drug Co. Ltd (5 min.)




Is Korean Drug Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$54.3m$58.7m-$3.3m-6.0%

How much money is Korean Drug Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$217.3k$953.7k-$1.1m-538.8%
Net Profit Margin-1.8%7.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Korean Drug Co. Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Korean Drug Co. Ltd?

Welcome investor! Korean Drug Co. Ltd's management wants to use your money to grow the business. In return you get a share of Korean Drug Co. Ltd.

First you should know what it really means to hold a share of Korean Drug Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of Korean Drug Co. Ltd is ₩4,560. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Korean Drug Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Korean Drug Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩7,196.40. Based on the TTM, the Book Value Change Per Share is ₩-84.55 per quarter. Based on the YOY, the Book Value Change Per Share is ₩42.94 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩37.47 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Korean Drug Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.070.0%-0.020.0%0.090.0%0.090.0%0.090.0%
Usd Book Value Change Per Share-0.070.0%-0.060.0%0.030.0%0.050.0%0.170.0%
Usd Dividend Per Share0.000.0%0.030.0%0.120.0%0.090.0%0.070.0%
Usd Total Gains Per Share-0.070.0%-0.030.0%0.150.0%0.140.0%0.250.0%
Usd Price Per Share3.89-4.55-4.98-5.80-5.73-
Price to Earnings Ratio-13.46--0.52-3.34-7.42-10.35-
Price-to-Total Gains Ratio-53.51--1.51-9.11-34.04-44.82-
Price to Book Ratio0.77-0.89-0.91-1.21-1.30-
Price-to-Total Gains Ratio-53.51--1.51-9.11-34.04-44.82-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.192
Number of shares313
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.09
Usd Book Value Change Per Share-0.060.05
Usd Total Gains Per Share-0.030.14
Gains per Quarter (313 shares)-10.3143.78
Gains per Year (313 shares)-41.26175.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
133-74-5111164165
266-148-92223127340
399-222-133334191515
4131-296-174446255690
5164-371-215557319865
6197-445-2566683821040
7230-519-2977804461215
8263-593-3388915101390
9296-667-37910025741565
10328-741-42011146371740

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%9.03.00.075.0%16.04.00.080.0%24.05.00.082.8%24.05.00.082.8%
Book Value Change Per Share2.02.00.050.0%9.03.00.075.0%15.05.00.075.0%22.07.00.075.9%22.07.00.075.9%
Dividend per Share1.00.03.025.0%9.00.03.075.0%17.00.03.085.0%25.00.04.086.2%25.00.04.086.2%
Total Gains per Share2.02.00.050.0%9.03.00.075.0%17.03.00.085.0%25.04.00.086.2%25.04.00.086.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Korean Drug Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---103.720-84.551-18%42.938-342%72.712-243%248.152-142%
Book Value Per Share--7196.4017335.816-2%7773.850-7%6952.312+4%6456.182+11%
Current Ratio--5.9625.198+15%6.407-7%6.427-7%6.550-9%
Debt To Asset Ratio--0.1600.182-12%0.162-2%0.161-1%0.156+2%
Debt To Equity Ratio--0.1900.224-15%0.197-4%0.193-2%0.187+2%
Dividend Per Share---37.472-100%174.824-100%127.083-100%103.509-100%
Eps---103.052-28.767-72%126.215-182%131.389-178%127.627-181%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap49223376000.000-22%59910030000.00070218873000.000-15%76776592500.000-22%89755076975.000-33%88970705155.172-33%
Net Profit Margin---0.059-0.018-68%0.070-184%0.077-176%0.081-172%
Operating Margin----0%0.099-100%0.079-100%0.076-100%
Operating Ratio--0.8911.216-27%1.087-18%0.905-1%1.100-19%
Pb Ratio0.634-22%0.7710.888-13%0.915-16%1.210-36%1.300-41%
Pe Ratio-11.062+18%-13.464-0.519-96%3.338-503%7.422-281%10.354-230%
Price Per Share4560.000-22%5550.0006505.000-15%7112.500-22%8279.000-33%8191.034-32%
Price To Free Cash Flow Ratio---3.282-100%5.934-100%3.696-100%4.190-100%
Price To Total Gains Ratio-43.965+18%-53.510-1.514-97%9.113-687%34.039-257%44.817-219%
Quick Ratio---2.015-100%6.031-100%5.632-100%5.336-100%
Return On Assets---0.012-0.005-59%0.015-182%0.016-174%0.017-171%
Return On Equity---0.014-0.005-67%0.015-193%0.019-176%0.020-172%
Total Gains Per Share---103.720-47.079-55%217.763-148%199.795-152%351.661-129%
Usd Book Value--54377590.40055431040.063-2%58740922.751-7%52712149.120+3%49040499.686+11%
Usd Book Value Change Per Share---0.073-0.059-18%0.030-342%0.051-243%0.174-142%
Usd Book Value Per Share--5.0375.135-2%5.442-7%4.867+4%4.519+11%
Usd Dividend Per Share---0.026-100%0.122-100%0.089-100%0.072-100%
Usd Eps---0.072-0.020-72%0.088-182%0.092-178%0.089-181%
Usd Free Cash Flow----2577261.6260%706629.075-100%619607.301-100%497496.132-100%
Usd Market Cap34456363.200-22%41937021.00049153211.100-15%53743614.750-22%62828553.883-33%62279493.609-33%
Usd Price Per Share3.192-22%3.8854.554-15%4.979-22%5.795-33%5.734-32%
Usd Profit---778681.400-217368.506-72%953712.247-182%995477.621-178%969196.983-180%
Usd Revenue--13276601.80013636454.185-3%14525723.875-9%12984707.031+2%11927140.393+11%
Usd Total Gains Per Share---0.073-0.033-55%0.152-148%0.140-152%0.246-129%
 EOD+3 -4MRQTTM+8 -21YOY+7 -245Y+11 -2010Y+9 -22

3.3 Fundamental Score

Let's check the fundamental score of Korean Drug Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.062
Price to Book Ratio (EOD)Between0-10.634
Net Profit Margin (MRQ)Greater than0-0.059
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than15.962
Debt to Asset Ratio (MRQ)Less than10.160
Debt to Equity Ratio (MRQ)Less than10.190
Return on Equity (MRQ)Greater than0.15-0.014
Return on Assets (MRQ)Greater than0.05-0.012
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Korean Drug Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.094
Ma 20Greater thanMa 504,695.500
Ma 50Greater thanMa 1004,885.500
Ma 100Greater thanMa 2005,105.800
OpenGreater thanClose4,610.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Korean Drug Co. Ltd

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-11-18 07:45:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Korean Drug Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Korean Drug Co. Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of -5.9% means that ₩-0.06 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Korean Drug Co. Ltd:

  • The MRQ is -5.9%. The company is making a loss. -1
  • The TTM is -1.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-5.9%TTM-1.8%-4.0%
TTM-1.8%YOY7.0%-8.8%
TTM-1.8%5Y7.7%-9.6%
5Y7.7%10Y8.1%-0.4%
4.3.1.2. Return on Assets

Shows how efficient Korean Drug Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Korean Drug Co. Ltd to the Drug Manufacturers - General industry mean.
  • -1.2% Return on Assets means that Korean Drug Co. Ltd generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Korean Drug Co. Ltd:

  • The MRQ is -1.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM-0.5%-0.7%
TTM-0.5%YOY1.5%-2.0%
TTM-0.5%5Y1.6%-2.1%
5Y1.6%10Y1.7%-0.1%
4.3.1.3. Return on Equity

Shows how efficient Korean Drug Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Korean Drug Co. Ltd to the Drug Manufacturers - General industry mean.
  • -1.4% Return on Equity means Korean Drug Co. Ltd generated ₩-0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Korean Drug Co. Ltd:

  • The MRQ is -1.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-0.5%-1.0%
TTM-0.5%YOY1.5%-2.0%
TTM-0.5%5Y1.9%-2.4%
5Y1.9%10Y2.0%-0.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Korean Drug Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Korean Drug Co. Ltd is operating .

  • Measures how much profit Korean Drug Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Korean Drug Co. Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Korean Drug Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY9.9%-9.9%
TTM-5Y7.9%-7.9%
5Y7.9%10Y7.6%+0.3%
4.3.2.2. Operating Ratio

Measures how efficient Korean Drug Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.89 means that the operating costs are ₩0.89 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Korean Drug Co. Ltd:

  • The MRQ is 0.891. The company is less efficient in keeping operating costs low.
  • The TTM is 1.216. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.891TTM1.216-0.324
TTM1.216YOY1.087+0.129
TTM1.2165Y0.905+0.311
5Y0.90510Y1.100-0.195
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Korean Drug Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Korean Drug Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 5.96 means the company has ₩5.96 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Korean Drug Co. Ltd:

  • The MRQ is 5.962. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.198. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.962TTM5.198+0.764
TTM5.198YOY6.407-1.209
TTM5.1985Y6.427-1.229
5Y6.42710Y6.550-0.123
4.4.3.2. Quick Ratio

Measures if Korean Drug Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Korean Drug Co. Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Korean Drug Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.015-2.015
TTM2.015YOY6.031-4.016
TTM2.0155Y5.632-3.616
5Y5.63210Y5.336+0.296
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Korean Drug Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Korean Drug Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Korean Drug Co. Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.16 means that Korean Drug Co. Ltd assets are financed with 16.0% credit (debt) and the remaining percentage (100% - 16.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Korean Drug Co. Ltd:

  • The MRQ is 0.160. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.182. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.160TTM0.182-0.022
TTM0.182YOY0.162+0.019
TTM0.1825Y0.161+0.021
5Y0.16110Y0.156+0.004
4.5.4.2. Debt to Equity Ratio

Measures if Korean Drug Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Korean Drug Co. Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 19.0% means that company has ₩0.19 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Korean Drug Co. Ltd:

  • The MRQ is 0.190. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.224. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.190TTM0.224-0.035
TTM0.224YOY0.197+0.028
TTM0.2245Y0.193+0.031
5Y0.19310Y0.187+0.007
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Korean Drug Co. Ltd generates.

  • Above 15 is considered overpriced but always compare Korean Drug Co. Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of -13.46 means the investor is paying ₩-13.46 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Korean Drug Co. Ltd:

  • The EOD is -11.062. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.464. Based on the earnings, the company is expensive. -2
  • The TTM is -0.519. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.062MRQ-13.464+2.402
MRQ-13.464TTM-0.519-12.945
TTM-0.519YOY3.338-3.857
TTM-0.5195Y7.422-7.941
5Y7.42210Y10.354-2.933
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Korean Drug Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.282-3.282
TTM3.282YOY5.934-2.652
TTM3.2825Y3.696-0.414
5Y3.69610Y4.190-0.494
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Korean Drug Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 0.77 means the investor is paying ₩0.77 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Korean Drug Co. Ltd:

  • The EOD is 0.634. Based on the equity, the company is cheap. +2
  • The MRQ is 0.771. Based on the equity, the company is cheap. +2
  • The TTM is 0.888. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.634MRQ0.771-0.138
MRQ0.771TTM0.888-0.116
TTM0.888YOY0.915-0.027
TTM0.8885Y1.210-0.322
5Y1.21010Y1.300-0.090
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets92,436,132
Total Liabilities14,753,860
Total Stockholder Equity77,682,272
 As reported
Total Liabilities 14,753,860
Total Stockholder Equity+ 77,682,272
Total Assets = 92,436,132

Assets

Total Assets92,436,132
Total Current Assets67,273,068
Long-term Assets25,163,065
Total Current Assets
Total Current Assets  (as reported)67,273,068
Total Current Assets  (calculated)0
+/- 67,273,068
Long-term Assets
Long-term Assets  (as reported)25,163,065
Long-term Assets  (calculated)0
+/- 25,163,065

Liabilities & Shareholders' Equity

Total Current Liabilities11,282,807
Long-term Liabilities3,471,053
Total Stockholder Equity77,682,272
Total Current Liabilities
Total Current Liabilities  (as reported)11,282,807
Total Current Liabilities  (calculated)0
+/- 11,282,807
Long-term Liabilities
Long-term Liabilities  (as reported)3,471,053
Long-term Liabilities  (calculated)0
+/- 3,471,053
Total Stockholder Equity
Total Stockholder Equity (as reported)77,682,272
Total Stockholder Equity (calculated)0
+/- 77,682,272
Other
Common Stock Shares Outstanding 10,789
Net Working Capital 55,990,261



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
63,126,186
65,431,933
66,794,035
65,969,943
66,703,097
67,269,361
72,962,058
74,579,028
73,075,307
72,766,219
75,849,501
77,982,200
81,273,158
83,640,907
83,344,757
87,557,785
85,882,404
88,148,325
88,612,611
91,416,137
91,665,552
97,947,311
94,516,358
103,593,788
105,389,797
109,488,292
89,709,048
96,746,719
92,436,132
92,436,13296,746,71989,709,048109,488,292105,389,797103,593,78894,516,35897,947,31191,665,55291,416,13788,612,61188,148,32585,882,40487,557,78583,344,75783,640,90781,273,15877,982,20075,849,50172,766,21973,075,30774,579,02872,962,05867,269,36166,703,09765,969,94366,794,03565,431,93363,126,186
   > Total Current Assets 
44,935,468
46,585,709
48,730,385
48,038,910
46,437,402
49,704,674
50,934,707
51,996,999
49,784,197
49,468,506
51,534,642
54,497,876
56,370,337
60,361,427
62,955,564
67,676,346
65,688,858
68,558,198
70,449,633
73,771,573
74,572,300
77,688,802
72,616,550
80,700,806
80,842,913
83,389,881
63,425,721
70,767,716
67,273,068
67,273,06870,767,71663,425,72183,389,88180,842,91380,700,80672,616,55077,688,80274,572,30073,771,57370,449,63368,558,19865,688,85867,676,34662,955,56460,361,42756,370,33754,497,87651,534,64249,468,50649,784,19751,996,99950,934,70749,704,67446,437,40248,038,91048,730,38546,585,70944,935,468
       Cash And Cash Equivalents 
3,828,817
4,470,454
2,396,756
2,677,848
3,129,155
4,617,090
5,480,002
7,498,454
6,582,133
7,577,352
6,105,482
6,492,932
8,312,786
8,574,415
6,905,248
7,716,352
7,577,378
5,453,800
164,515
0
0
0
182,183
14,228,852
12,517,881
15,586,035
11,688,942
7,560,274
0
07,560,27411,688,94215,586,03512,517,88114,228,852182,183000164,5155,453,8007,577,3787,716,3526,905,2488,574,4158,312,7866,492,9326,105,4827,577,3526,582,1337,498,4545,480,0024,617,0903,129,1552,677,8482,396,7564,470,4543,828,817
       Short-term Investments 
806,804
0
752,577
752,016
794,732
0
3,141,496
3,183,422
3,222,927
3,287,429
5,254,949
0
0
11,337,366
15,161,713
17,220,584
17,263,380
20,313,466
23,039,157
25,938,258
17,982,629
24,944,458
22,990,357
21,699,624
21,238,970
21,246,244
5,066,781
9,742,022
0
09,742,0225,066,78121,246,24421,238,97021,699,62422,990,35724,944,45817,982,62925,938,25823,039,15720,313,46617,263,38017,220,58415,161,71311,337,366005,254,9493,287,4293,222,9273,183,4223,141,4960794,732752,016752,5770806,804
       Net Receivables 
30,439,229
32,241,261
36,098,684
33,030,678
32,653,846
31,933,139
32,891,440
29,163,187
29,290,654
27,719,844
28,080,013
26,580,583
28,341,267
28,151,709
27,893,820
27,850,458
27,153,103
27,558,044
28,500,995
27,993,602
29,850,203
31,925,393
31,459,943
28,757,614
29,473,814
29,451,545
27,853,873
27,620,217
0
027,620,21727,853,87329,451,54529,473,81428,757,61431,459,94331,925,39329,850,20327,993,60228,500,99527,558,04427,153,10327,850,45827,893,82028,151,70928,341,26726,580,58328,080,01327,719,84429,290,65429,163,18732,891,44031,933,13932,653,84633,030,67836,098,68432,241,26130,439,229
       Inventory 
9,426,103
9,391,635
9,074,006
11,006,784
9,468,315
10,296,929
9,382,876
11,811,085
10,646,904
10,815,405
11,839,201
12,992,996
11,299,549
11,972,667
10,744,399
11,924,514
11,718,163
13,158,640
12,893,706
13,094,992
12,882,593
13,331,867
13,775,192
14,677,863
14,875,358
16,623,053
18,341,146
20,297,331
0
020,297,33118,341,14616,623,05314,875,35814,677,86313,775,19213,331,86712,882,59313,094,99212,893,70613,158,64011,718,16311,924,51410,744,39911,972,66711,299,54912,992,99611,839,20110,815,40510,646,90411,811,0859,382,87610,296,9299,468,31511,006,7849,074,0069,391,6359,426,103
       Other Current Assets 
392,580
433,142
408,363
539,681
31,876
37,054
27,351
336,184
36,663
41,011
78,801
83,786
87,030
309,981
2,075,345
2,362,294
1,971,007
2,056,862
512,000
254,000
933,305
818,650
949,194
0
0
0
-1
0
0
00-1000949,194818,650933,305254,000512,0002,056,8621,971,0072,362,2942,075,345309,98187,03083,78678,80141,01136,663336,18427,35137,05431,876539,681408,363433,142392,580
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,899,808
22,892,982
24,546,884
26,098,411
26,283,327
25,979,003
25,163,065
25,163,06525,979,00326,283,32726,098,41124,546,88422,892,98221,899,8080000000000000000000000
       Property Plant Equipment 
14,614,391
14,798,109
14,878,391
14,762,227
15,397,034
12,567,472
12,630,175
12,452,034
13,695,176
14,701,399
14,849,338
14,868,151
14,735,293
14,605,757
13,784,216
14,148,667
14,038,064
13,939,168
13,998,990
13,757,092
14,289,141
17,376,016
18,606,846
19,606,879
21,092,608
22,709,522
22,999,179
22,763,930
0
022,763,93022,999,17922,709,52221,092,60819,606,87918,606,84617,376,01614,289,14113,757,09213,998,99013,939,16814,038,06414,148,66713,784,21614,605,75714,735,29314,868,15114,849,33814,701,39913,695,17612,452,03412,630,17512,567,47215,397,03414,762,22714,878,39114,798,10914,614,391
       Long Term Investments 
1,217,628
1,217,628
229,039
229,039
808,473
724,766
4,952,115
5,795,561
4,893,659
4,051,262
4,714,371
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000004,714,3714,051,2624,893,6595,795,5614,952,115724,766808,473229,039229,0391,217,6281,217,628
       Intangible Assets 
901,752
875,183
834,258
797,733
761,108
781,339
747,031
711,088
674,451
682,272
661,216
689,277
678,582
405,753
683,895
623,438
566,065
327,951
274,128
216,569
174,323
245,438
501,661
445,493
403,726
405,902
362,803
318,179
0
0318,179362,803405,902403,726445,493501,661245,438174,323216,569274,128327,951566,065623,438683,895405,753678,582689,277661,216682,272674,451711,088747,031781,339761,108797,733834,258875,183901,752
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
413,181
413,181
413,181
413,181
413,181
413,181
0
0413,181413,181413,181413,181413,181413,1810000000000000000000000
> Total Liabilities 
9,072,082
10,182,343
9,820,852
9,441,962
9,955,090
9,453,569
10,162,562
11,713,944
10,492,103
10,891,010
10,799,788
13,502,801
13,071,025
14,020,308
12,473,966
15,772,207
12,382,506
13,711,023
11,922,709
13,755,524
12,186,502
14,840,663
9,803,725
17,083,703
24,056,748
26,313,731
12,618,965
17,944,834
14,753,860
14,753,86017,944,83412,618,96526,313,73124,056,74817,083,7039,803,72514,840,66312,186,50213,755,52411,922,70913,711,02312,382,50615,772,20712,473,96614,020,30813,071,02513,502,80110,799,78810,891,01010,492,10311,713,94410,162,5629,453,5699,955,0909,441,9629,820,85210,182,3439,072,082
   > Total Current Liabilities 
6,496,444
7,412,022
8,602,423
8,229,433
7,076,743
6,293,555
6,561,257
7,769,616
6,386,484
6,600,726
6,523,079
8,417,814
7,630,439
8,474,131
9,771,195
12,979,218
9,460,667
10,401,978
10,329,034
11,912,087
9,885,059
12,056,330
7,411,697
14,468,667
21,226,108
23,094,228
9,902,148
14,698,760
11,282,807
11,282,80714,698,7609,902,14823,094,22821,226,10814,468,6677,411,69712,056,3309,885,05911,912,08710,329,03410,401,9789,460,66712,979,2189,771,1958,474,1317,630,4398,417,8146,523,0796,600,7266,386,4847,769,6166,561,2576,293,5557,076,7438,229,4338,602,4237,412,0226,496,444
       Short-term Debt 
1,000,000
1,000,000
500,000
500,000
500,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000500,000500,000500,0001,000,0001,000,000
       Short Long Term Debt 
1,000,000
1,000,000
500,000
500,000
500,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000500,000500,000500,0001,000,0001,000,000
       Accounts payable 
3,820,372
3,295,932
3,458,360
3,237,340
3,177,671
2,846,147
2,663,440
3,502,985
3,473,346
3,537,353
3,065,777
4,370,514
3,471,334
4,155,140
2,662,110
4,282,994
3,277,188
4,426,611
0
0
4,061,937
5,494,674
4,551
3,940,932
4,662,027
5,337,415
1,920,784
4,982,888
0
04,982,8881,920,7845,337,4154,662,0273,940,9324,5515,494,6744,061,937004,426,6113,277,1884,282,9942,662,1104,155,1403,471,3344,370,5143,065,7773,537,3533,473,3463,502,9852,663,4402,846,1473,177,6713,237,3403,458,3603,295,9323,820,372
       Other Current Liabilities 
1,628,472
3,043,176
4,144,063
3,511,310
2,384,882
2,777,453
3,201,741
3,510,895
2,073,143
2,342,295
2,642,176
3,222,944
3,212,626
3,310,422
6,088,995
7,776,878
5,066,952
4,903,508
0
0
4,667,140
5,341,017
5,451,693
2,551,090
1,717,576
1,853,705
2,054,539
2,047,082
0
02,047,0822,054,5391,853,7051,717,5762,551,0905,451,6935,341,0174,667,140004,903,5085,066,9527,776,8786,088,9953,310,4223,212,6263,222,9442,642,1762,342,2952,073,1433,510,8953,201,7412,777,4532,384,8823,511,3104,144,0633,043,1761,628,472
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,392,028
2,615,036
2,830,640
3,219,503
2,716,817
3,246,074
3,471,053
3,471,0533,246,0742,716,8173,219,5032,830,6402,615,0362,392,0280000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
96,761
25,883
13,300
10,873
18,077
6,162
2,320
9,157
22,253
14,998
32,131
28,716
32,116
21,731
0
0
0
0
0
0
00000021,73132,11628,71632,13114,99822,2539,1572,3206,16218,07710,87313,30025,88396,761000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
81,203
60,274
63,189
88,775
67,574
63,748
0
063,74867,57488,77563,18960,27481,2030000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,026,323
2,059,652
1,940,230
2,072,177
2,130,220
2,161,705
0
02,161,7052,130,2202,072,1771,940,2302,059,6522,026,3230000000000000000000000
> Total Stockholder Equity
54,054,104
55,249,590
56,973,183
56,527,981
56,748,007
57,815,792
62,799,496
62,865,084
62,583,204
61,875,209
65,049,712
64,479,399
68,202,133
69,620,599
70,870,791
71,785,578
73,499,897
74,437,302
76,689,902
77,660,613
79,479,050
83,106,648
84,712,633
86,510,085
81,333,049
83,174,560
77,090,083
78,801,885
77,682,272
77,682,27278,801,88577,090,08383,174,56081,333,04986,510,08584,712,63383,106,64879,479,05077,660,61376,689,90274,437,30273,499,89771,785,57870,870,79169,620,59968,202,13364,479,39965,049,71261,875,20962,583,20462,865,08462,799,49657,815,79256,748,00756,527,98156,973,18355,249,59054,054,104
   Common Stock
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
5,500,000
0
0
0
0
0
0
0000005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,0005,500,000
   Retained Earnings 
45,504,891
46,694,086
48,455,675
47,969,104
48,189,130
49,253,769
54,306,998
54,453,712
54,170,308
53,462,313
56,635,909
56,064,867
59,787,601
61,206,158
62,487,925
63,499,562
65,213,881
66,741,123
69,345,299
70,315,523
72,133,960
75,759,828
77,364,419
79,161,808
73,978,149
75,818,559
69,723,554
71,419,273
0
071,419,27369,723,55475,818,55973,978,14979,161,80877,364,41975,759,82872,133,96070,315,52369,345,29966,741,12365,213,88163,499,56262,487,92561,206,15859,787,60156,064,86756,635,90953,462,31354,170,30854,453,71254,306,99849,253,76948,189,13047,969,10448,455,67546,694,08645,504,891
   Accumulated Other Comprehensive Income 00000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
3,406,560
3,406,561
3,406,560
3,406,560
3,406,560
3,406,560
3,406,561
3,406,561
3,406,560
3,406,560
3,406,561
3,406,561
3,406,561
3,406,561
0
0
0
0
0
0
0000003,406,5613,406,5613,406,5613,406,5613,406,5603,406,5603,406,5613,406,5613,406,5603,406,5603,406,5603,406,5603,406,5613,406,560000000000
   Treasury Stock0000000000-1,585,714-1,232,387-636,732-636,732-536,164-498,854-498,854-498,854-499,327-500,002000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue81,374,983
Cost of Revenue-44,025,041
Gross Profit37,349,94237,349,942
 
Operating Income (+$)
Gross Profit37,349,942
Operating Expense-63,349,091
Operating Income18,025,892-25,999,149
 
Operating Expense (+$)
Research Development0
Selling General Administrative6,954,618
Selling And Marketing Expenses0
Operating Expense63,349,0916,954,618
 
Net Interest Income (+$)
Interest Income1,212,516
Interest Expense-3,017
Other Finance Cost-0
Net Interest Income1,209,499
 
Pretax Income (+$)
Operating Income18,025,892
Net Interest Income1,209,499
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,265,32018,025,892
EBIT - interestExpense = -3,017
-4,916,773
-4,913,756
Interest Expense3,017
Earnings Before Interest and Taxes (EBIT)08,268,337
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax8,265,320
Tax Provision-13,182,093
Net Income From Continuing Ops-4,916,773-4,916,773
Net Income-4,916,773
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,209,499
 

Technical Analysis of Korean Drug Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Korean Drug Co. Ltd. The general trend of Korean Drug Co. Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Korean Drug Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Korean Drug Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4,750 < 5,050 < 5,721.

The bearish price targets are: 4,440.

Tweet this
Korean Drug Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Korean Drug Co. Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Korean Drug Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Korean Drug Co. Ltd. The current macd is -104.32707893.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Korean Drug Co. Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Korean Drug Co. Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Korean Drug Co. Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Korean Drug Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartKorean Drug Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Korean Drug Co. Ltd. The current adx is 23.31.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Korean Drug Co. Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Korean Drug Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Korean Drug Co. Ltd. The current sar is 4,440.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Korean Drug Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Korean Drug Co. Ltd. The current rsi is 36.09. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Korean Drug Co. Ltd Daily Relative Strength Index (RSI) ChartKorean Drug Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Korean Drug Co. Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Korean Drug Co. Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Korean Drug Co. Ltd Daily Stochastic Oscillator ChartKorean Drug Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Korean Drug Co. Ltd. The current cci is -50.19512852.

Korean Drug Co. Ltd Daily Commodity Channel Index (CCI) ChartKorean Drug Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Korean Drug Co. Ltd. The current cmo is -26.53865161.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Korean Drug Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartKorean Drug Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Korean Drug Co. Ltd. The current willr is -73.03370787.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Korean Drug Co. Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Korean Drug Co. Ltd Daily Williams %R ChartKorean Drug Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Korean Drug Co. Ltd.

Korean Drug Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Korean Drug Co. Ltd. The current atr is 117.96.

Korean Drug Co. Ltd Daily Average True Range (ATR) ChartKorean Drug Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Korean Drug Co. Ltd. The current obv is 8,239,526.

Korean Drug Co. Ltd Daily On-Balance Volume (OBV) ChartKorean Drug Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Korean Drug Co. Ltd. The current mfi is 26.01.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Korean Drug Co. Ltd Daily Money Flow Index (MFI) ChartKorean Drug Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Korean Drug Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Korean Drug Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Korean Drug Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.094
Ma 20Greater thanMa 504,695.500
Ma 50Greater thanMa 1004,885.500
Ma 100Greater thanMa 2005,105.800
OpenGreater thanClose4,610.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Korean Drug Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on Korean Drug Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Korean Drug Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Korean Drug Co. Ltd

I send you an email if I find something interesting about Korean Drug Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Korean Drug Co. Ltd.

Receive notifications about Korean Drug Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.